Buyer	Department of Health and Social Care — not a council we hold
Supplier	PA CONSULTING SERVICES LIMITED

• The Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG) is a rebate scheme on the pharmaceutical industry which generates income for the NHS and controls the bottom line of the NHS budget. This is critical to the financial sustainability of the NHS by controlling how much the NHS spends on branded drugs - this is one of the largest commercial agreements in Government. VPAG also includes important elements that support the wider medicines environment, including supporting greater and timelier patient access to new clinically and cost-effective medicines, and support for innovation.

Runs	14 Apr 2025 to 15 Jul 2025
OCID	ocds-b5fd17-33ccd609-e5d8-4930-81d5-168f38896858
Notice	Read it on Contracts Finder

Figures are as published An award value in OCDS may be a framework ceiling rather than a sum anyone expects to spend, so a large figure here is not evidence of a large purchase.